Doximity's Stock Soars 36% After Strong Earnings Report
Doximity shares surged 36% after reporting impressive fiscal third-quarter earnings, surpassing revenue expectations and raising guidance. Analysts hailed it as a "statement quarter," highlighting strong growth and strategic expansion.
The stock of Doximity, the digital platform for medical professionals, saw a remarkable jump of 36% after it announced its fiscal third-quarter earnings. The company reported revenue of $168.6 million, up 25% from the same quarter last year, at $135.3 million. Analysts have termed the quarter as a defining moment, considering the strong financials and strategic advancements.
Financial Highlights
Revenue Growth: Doximity reported $168.6 million in revenue, a significant year-over-year increase.
EBITDA Performance: The company’s adjusted EBITDA stood at $102.0 million, reflecting a 39% increase.
Fourth-Quarter Revenue Outlook: Doximity projects revenue between $132.5 million and $133.5 million, surpassing Wall Street’s estimates of $123.8 million.
Full Fiscal Year Projection: The company now expects revenue in the range of $564.6 million to $565.6 million.
Market Reaction and Analyst Upgrades
Following the earnings report, multiple analysts upgraded Doximity’s stock price target:
Morgan Stanley: Raised the target from $53 to $71, driven by strong EBITDA and margin growth.
Bank of America: Raised its target from $63 to $75, based on Doximity's accelerating market share.
Leerink Partners: Upgraded the stock to outperform and raised its target from $60 to $90.
Growth Drivers
The reasons behind Doximity's healthy financial performance include the following:
Expansion of Telehealth Services: The company has enhanced its telehealth capabilities and enabled medical professionals to conduct easy virtual appointments.
Client Portal Introduced: This has increased engagement and revenue streams for the company.
AI Innovations: Doximity has invested considerably in AI tools to enhance the user experience and efficiency.
Rise in Spending on Elections: Political ad spend contributed to growth in revenue but may moderate going forward.
Market Differentiation: The company's capability to grow over 2X market growth is a testimony to its leadership in the segment.
Future Projections
In fiscal 2026, analysts expect Doximity to experience more modest growth. However, they are positive about its long-term prospects. The company can sustain healthy margins and build additional revenue streams to enhance market positioning. Doximity is seen to be going ahead in its bid to make its products and services outstrip competition through AI-powered innovation and strategic alliances.

FAQ Section
What helped propel Doximity's third quarter into the lead?
Doximity saw revenue jump due to an increase in telehealth utilization, introduction of a client portal, investment in AI, and increased election-related expense.
How did analysts react to Doximity's reported earnings?
Analysts were generally upbeat, with Morgan Stanley and Bank of America raising price targets after Doximity reported strong EBITDA growth and strategic expansion. Leerink Partners also raised its price target, according to Wall Street Journal.
What does Doximity expect in terms of revenue for the next quarter?
The company expects fourth-quarter revenue between $132.5 million and $133.5 million, which is above Wall Street's estimate of $123.8 million.
What are some of the challenges that Doximity may face in the future?
Some of the potential challenges include a slowdown in revenue growth post-election, increased competition in the digital health sector, and the need for continuous innovation to maintain its lead.
What makes Doximity different from its competitors?
Doximity's unique combination of telehealth services, AI-driven solutions, and exclusive medical professional networking sets it apart from traditional digital health platforms.
Doximity's outstanding third-quarter earnings speak to its strong market positioning and continued innovation. With a promising outlook and strategic initiatives in place, the company remains a key player in the digital healthcare space.